Regulatory Expertise Jordi Labs specializes in regulator-credible testing and toxicology, particularly in chemical and material characterization, extractables and leachables testing, and risk assessments. This positions the company as a valuable partner for MedTech firms seeking to ensure compliance and streamline their regulatory submissions.

Innovative Solutions The company has recently launched advanced products such as the SMART Solutions lifecycle partnership model and fern.ai Smart Authoring, demonstrating its commitment to innovative, technology-driven services that enhance post-market surveillance and regulatory documentation, offering potential upsell opportunities.

Strategic Partnerships Recent collaborations with firms like 3Aware Inc. highlight Jordi Labs’ focus on integrating real-world evidence and post-market activities, creating growth avenues for clients seeking streamlined PMCF processes and stronger data-driven decision-making in the MedTech industry.

Growth and Expansion With a revenue range of 100M to 250M and recent leadership changes including new CEO appointments, Jordi Labs is positioned for expansion, making it an attractive target for companies looking to partner with a growing, innovative player in the regulatory testing space.

Market Position As part of RQM+, Jordi Labs operates within a competitive landscape alongside large firms like SGS and Eurofins, yet its specialized focus on MedTech and rapid adoption of digital solutions offers opportunities for clients seeking niche expertise and faster time-to-market for their products.